Oramed Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Other companies in the scoring peer group for Oramed Pharmaceuticals Inc are displayed below. The ESG rating includes seventeen United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'. Comprehensive Sustainability assessment of Oramed Pharmaceuticals Inc can be reached by logging in.
Oramed Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 4.8, social score of 3.2 and governance score of 5.3.
4.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Novartis AG | 9.2 | High |
2 | Daiichi Sankyo Co Ltd | 8.9 | High |
1252 | Wntresearch AB | 4.5 | High |
1252 | Verano Holdings Corp | 4.5 | High |
1284 | Oramed Pharmaceuticals Inc | 4.4 | High |
1284 | Adinath Biolabs Ltd | 4.4 | High |
1284 | Aligos Therapeutics Inc | 4.4 | High |
... | ... | ... | |
2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
2749 | Zyden Gentec Ltd | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Oramed Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Oramed Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oramed Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oramed Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Oramed Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oramed Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oramed Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.